Arm vein conduit is superior to composite prosthetic-autogenous grafts in lower extremity revascularization  by Faries, Peter L. et al.
Greater saphenous vein (GSV) is the preferred
conduit for infrainguinal revascularization.1-11
However, up to 45% of patients seen with critical
lower extremity ischemia do not possess a usable
ipsilateral GSV.1,12,13 Consequently, the question of
what alternative conduit should be used in the
absence of an adequate ipsilateral GSV has arisen.14
The alternative conduits may be generally divided
into autogenous and non-autogenous, or prosthetic,
groups. Prosthetic conduit bypass grafts to the
popliteal artery have achieved moderate success.8,15
Prosthetic grafts to the tibial vessels have also been
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Purpose: Various alternative conduits have been used for lower extremity revasculariza-
tion when an adequate ipsilateral greater saphenous vein is absent. This study compared
the effectiveness of all-autogenous multisegment arm vein bypass grafts with that of
composite grafts composed of combined prosthetic and autogenous conduits.
Methods: One hundred fifty-three lower extremity revascularization procedures per-
formed between 1990 and 1998 were followed up prospectively using a computerized
vascular registry. The grafts were composed of spliced arm vein segments with ven-
ovenostomy in 122 and of composite prosthetic-autogenous conduit in 31. Arm vein
conduit was prepared by means of intraoperative angioscopy for valve lysis and identifi-
cation of luminal abnormalities in 47.7% of cases.
Results: Bypass graft configurations were as follows: femoropopliteal (12 arm vein, 2
composite); femorotibial (75 arm vein, 23 composite); femoropedal (14 arm vein, 6
composite), and popliteo-tibial/pedal (21 arm vein, 0 composite). The indication for
surgery was limb salvage in 98% and disabling claudication in 2% of cases. The mean fol-
low-up was 25.1 months (range, 1 month to 7.9 years). Overall survival at 4 years was
51%. Overall patency and limb salvage rates were as follows: primary patency, at 1 year—
arm vein, 76.9% ± 4.8%; composite, 59.5% ± 9.6% (P = .02); at 3 years—arm vein, 70.0%
± 8.0%; composite, 43.7% ± 12.4% (P < .01); and at 5 years—arm vein, 53.8% ± 8.7%;
composite, 0%; secondary patency, at 1 year—arm vein, 77.5% ± 4.6%; composite, 59.8%
± 9.5% (P = .02); at 3 years—arm vein, 70.7% ± 7.5%, composite, 44.9% ± 13.1% (P <
.01); at 5 years—arm vein, 57.7% ± 8.0%; composite, 0%; limb salvage, at 1 year—arm
vein, 89.3% ± 3.7%; composite, 73.9% ± 8.9% (P < .01); at 3 years—arm vein, 80.5% ±
7.0%; composite, 49.6% ± 14.3% (P < .01); at 5 years—arm vein, 76.3% ± 9.9%; com-
posite, 0%.
Conclusion: In this study, multisegment autogenous arm vein was used successfully in a
wide variety of lower extremity revascularization procedures and achieved good long-
term patency and limb salvage rates, well in excess of those achieved with composite
prosthetic-autogenous grafts. The use of autogenous conduit appears to offer superior
results to composite conduit in lower extremity revascularization. The superior durabil-
ity of arm vein makes it one of the alternative conduits of choice when an adequate
greater saphenous vein is not available. (J Vasc Surg 2000;31:1119-27.)
performed with results that justify their use as an
alternative to primary amputation.16 However, the
effectiveness of prosthetic grafts below the knee has
been found inferior to that of all-autogenous con-
duits in the majority of studies. When only a short
segment of autogenous vein is required for revascu-
larization, such as in a tibiotibial bypass or a revision
“jump” graft, a single segment of alternative auto-
genous vein may be relatively easily obtained.
Alternative autogenous veins include cephalic and
basilic arm vein, lesser saphenous vein, and remnants
of the GSV.17-20 Frequently, however, the length of
conduit required cannot be obtained by using a sin-
gle segment of alternative vein, and two or more
segments must be spliced together. Some authors
have expressed concern that the performance of a
venovenostomy may lead to the development of inti-
mal hyperplasia and vein graft failure.
These factors have prompted attempts to com-
bine prosthetic and autogenous conduit to achieve a
bypass graft of a length suitable for long lower
extremity bypasses, while attempting to maintain the
superior results achieved with all-autogenous
grafts.10,21-24 These grafts have been placed with
both sequential configurations and with primary
anastomoses between the prosthetic conduit and the
autogenous vein. Alternatively, modifications includ-
ing placement of a cuff or a patch of autogenous
vein at the distal anastomosis have been used suc-
cessfully at a limited number of institutions.25 This
study examined the effects of conduit type on the
outcome of long-length infrainguinal arterial recon-
structive procedures. Conduits composed of two or
more segments of autogenous arm vein spliced
together were compared with composite conduits
composed of prosthetic graft material proximally
and autogenous vein distally.
PATIENTS AND METHODS
Database and patient demographics. From
January 1, 1990, to August 31, 1998, a consecutive
series of 3019 infrainguinal arterial reconstructions
were performed. All data regarding each patient,
procedure, and follow-up were entered prospective-
ly in a computerized vascular registry. These data
were then reviewed retrospectively. During this
time, 122 bypass procedures were performed using
multiple segments of arm vein with venovenostomy.
In addition, 31 procedures were performed using
composite graft composed of prosthetic conduit
proximally (24 polytetrafluoroethylene [PTFE], 7
Dacron) and autogenous vein distally. The demo-
graphics of the 153 patients are shown in Table I. All
procedures were performed in the absence of an
adequate ipsilateral GSV. Prosthetic conduit was
used when adequate autogenous conduit was
unavailable. The majority (150, 98%) of the revascu-
larization procedures were performed for limb sal-
vage, including gangrene in 39 (25.5%), ischemic
ulcer in 93 (60.8%), and ischemic rest pain in 18
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Fig 1. Life-table analysis of the variation in primary paten-
cy rates categorized by type of conduit. Multisegment arm
vein grafts (solid line/solid circles) demonstrated signifi-
cantly higher patency rates at all time points after 30-days
compared with composite grafts (dashed line/open circles).





History of recent smoking 78 74
CAD 63 71
Previous CABG or PTCA 41 48
Hypertension 64 68
ESRD 15 10
Average age (y) 72.4 68.1 
CAD, Coronary artery disease; CABG, coronary artery bypass
grafting; PTCA, percutaneous transluminal coronary angioplasty;
ESRD, end-stage renal disease.
Table II. Anatomic configuration of revasculariza-
tion procedure
Arm vein no. Composite no.
Graft configuration (%) (%)
Femoropopliteal 12 (9.8) 2 (6.5)
Femorotibial 75 (61.5) 23 (74.2)
Femoropedal 14 (11.5) 6 (19.4)
Popliteo-tibial/pedal 21 (17.2) 0
(11.8%). Only 3 (2%) revascularizations were per-
formed for treatment of disabling claudication.
Bypass was performed as the initial procedure in 60
(49.2%) arm vein cases and 12 (38.7%) composite
cases and as redo bypass procedures in 64 (50.8%)
arm vein cases and 19 (61.3%) composite cases.
Twelve grafts were composite sequential, and 19
were in-line composite or shared a common ostium.
There was no crossover between groups. The defin-
itions and classification of all criteria used were those
recommended by the Ad Hoc Committee on
Reporting Standards, SVS/NA-ISCVS.26
Vein graft preparation. After harvest through
continuous upper extremity incisions, the arm vein
was maintained in cooled balanced salt solution to
preserve vessel wall integrity, as described previous-
ly.13,27 During 47.7% of the procedures, angioscopy
was used to assess the luminal characteristics of the
arm vein and perform valve lysis.28 Angioscopy was
not performed in instances in which the arm vein
was used in the reversed configuration or if short
vein segments were used in which valve lysis 
could be performed under direct visualization.
Angioscopes ranged in size from 0.8 to 2.2 mm in
outer diameter (Olympus Corp, Lake Success, NY).
Abnormalities were corrected either externally (vein
patch angioplasty) or by using angioscopic guidance
(removal of adherent thrombus, lysis of endoluminal
strands). Alternatively, resection of the abnormal
segments was performed when repair was not possi-
ble (vein sclerosis).
Venovenostomies were performed end-to-end by
using 7-0 polypropylene suture (Prolene; Ethicon,
Sommerville, NJ) to create a vein conduit of suffi-
cient length and quality to allow performance of the
lower extremity revascularization. Anastomoses
between prosthetic grafts and autogenous vein were
performed with CV-7 polytetrafluoroethylene suture
(W. L. Gore, Flagstaff, Ariz) or 6-0 polypropylene
suture. The specific arterial reconstructive proce-
dures performed are listed in Table II.
Postoperative follow-up. During the first year,
patients were followed up with office visits every 3
months; visits were every 6 months thereafter. Graft
patency was determined by means of clinical exami-
nation of pulses distal to the bypass graft, as well as
by continuous-wave Doppler examination. Selective
color-flow duplex examination was also performed
to determine graft patency or define flow abnormal-
ities. The criteria for patency and the definitions of
primary, assisted primary, and secondary patency,
limb salvage, and survival rates used in this study are
those outlined by the Ad Hoc Committee on
Reporting Standards, SVS/NA-ISCVS.26 Follow-up
ranged from 1 month to 7.9 years, with an average
follow-up of 25.1 months.
Statistical analysis. Life-table analysis was used
to calculate patency, limb salvage, and survival rates.
Comparison between life-table curves was per-
formed by using the Mantel-Cox log-rank test for
significance. Figures are represented as the mean ±
standard error. Other continuous variables were
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Fig 2. Life-table analysis of the variation in secondary patency rates categorized by type of conduit.
Again, multisegment arm vein grafts (solid line/solid circles) were superior to composite grafts (dashed
line/open circles).
compared with the Student t test, and discrete para-
meters were compared using chi-squared analysis.
Significance was assumed at P less than .05.
RESULTS
Morbidity and mortality. The overall perioper-
ative systemic morbidity rate was 11.5% for arm vein
graft procedures and 12.9% for composite graft pro-
cedures (P = NS). The perioperative local complica-
tion rates were 11.5% and 12.8%, respectively (P =
NS). Complications—including myocardial infarc-
tion, pulmonary failure necessitating intubation,
renal failure requiring dialysis, pneumonia,
hematoma, wound infection, graft infection, and
wound dehiscence—did not differ significantly
between groups (Table III). A return to the operat-
ing room was required for 6 patients (3.9%). The
30-day mortality rate was 2.5% for arm vein proce-
dures and 3.2% for composite procedures (P = NS).
This was not significantly different from the rate for
all lower extremity revascularization procedures at
our institution during the same period. Morbidity
resulting from arm vein harvest occurred in 2
patients (1.6%). This consisted of numbness involv-
ing the volar aspect of the forearm.
Graft patency, limb salvage, and survival.
Cumulative patency and limb salvage rates for mul-
tisegment arm vein conduit were superior to those
observed for composite prosthetic-autogenous con-
duits. Primary patency is depicted in Fig 1. Primary
patency for multisegment arm vein grafts was greater
than that of composite grafts at all time points after
30 days. The 3-year rates were as follows: arm vein,
70.0% ± 8.0%; composite, 43.7% ± 12.4% (P < .01)
(of note, results beyond 3 years for the composite
group have a standard error that exceeds 10% (Fig
1). Similarly, the cumulative secondary patency rates
were significantly higher for multisegment arm vein
grafts compared with composite grafts (Fig 2). The
3-year secondary patency rates were as follows: arm
vein, 70.7% ± 7.5%; composite, 44.9% ± 13.1% (P <
.01). Only small differences were observed between
the primary and the secondary patency rates, and no
significant difference was observed based on the
number of venovenostomies performed. Limb sal-
vage rates demonstrated the greatest difference, with
multisegment arm vein conduit again being superior
by log-rank analysis (3-year, 80.5% ± 7.0%, vs 49.6%
± 14.3%, P < .01) (Fig 3).
Multisegment arm vein grafts demonstrated high-
er patency and limb salvage rates in all graft configu-
rations (femoropopliteal, femorotibial, femoropedal).
Cumulative patency and limb salvage were greater for
femoropopliteal and femorotibial grafts than for
femoropedal grafts. The femorotibial configuration
comprised the greatest proportion of bypass grafts
(arm vein, 75/122 (61.5%); composite, 23/31
(74.2%). The 4-year primary/secondary/limb salvage
rates for femorotibial grafts were as follows: arm vein,
58.0% ± 10.3%/59.0% ± 9.6%/83.6% ± 8.5%; com-
posite, 42.4% ± 12.1%/42.4% ± 12.1%/46.9% ±
13.3% (Fig 4). Overall survival was 51% at 4 years.
Lower extremity revascularization was per-
formed as the initial procedure in 60 (49.2%) arm
vein cases and in 12 (38.7%) composite cases and as
a revision procedure in 64 (51.8%) arm vein cases
and in 19 (61.3%) composite cases. No significant
difference was present between primary and redo
procedures.
DISCUSSION
Progressive improvement in vascular surgical
methods and practice has led to increased limb
preservation and reduced rates of lower extremity
amputation.29-31 Numerous reports from multiple
institutions have confirmed the effectiveness of
infrainguinal revascularization in producing superior
long-term patency and limb salvage rates.1-9
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Table III. Morbidity and mortality
Complication Type Arm vein no. (%) Composite no. (%)
Local complications Hematoma 9 (7.4) 3 (9.7)
Wound infection 2 (1.6) 0 (0)
Wound dehiscence 1 (0.8) 0 (0)
Hemorrhage 1 (0.8) 0 (0)
Graft infection 0 (0) 1 (3.2)
Systemic complications Myocardial infarction 3 (2.5) 2 (6.4)
Renal failure 1 (0.8) 0 (0)
Pulmonary failure 3 (2.5) 0 (0)
Pneumonia 7 (5.7) 2 (6.4)
30–day mortality 3 (2.5) 1 (3.2)
However, the need for alternative conduits for lower
extremity revascularization has become increasingly
evident, particularly when multiple procedures are
performed to salvage a single extremity.
The first use of arm vein as an alternative conduit
for lower extremity revascularization was reported in
1969.32 The effectiveness of arm vein for lower
extremity revascularization was confirmed by several
subsequent reports.20,33 Excellent long-term paten-
cy and limb salvage rates have recently been shown
in several studies involving large numbers of patients
who underwent infrainguinal revascularization with
arm vein conduit.13,34 Indeed, 5-year cumulative
patency and limb salvage rates up to 57.5 and 71.5%,
respectively, make arm vein an excellent alternative
when the GSV is not available for use.
Nevertheless, concern regarding the use of arm
vein for infrainguinal reconstructions has been
expressed, particularly when it is necessary to anasto-
mose multiple segments of vein to create an conduit of
adequate length for long-length bypass grafts.14,35
These concerns, and questions regarding the ability to
obtain adequate lengths of arm vein conduit, have led
several authors to propose the use of composite grafts
composed of prosthetic conduit and autogenous
vein.21-24 Two-year primary patency rates between
29% and 35% are reported with the use of these com-
posite grafts.22,24 These results are consistent with
those observed in the present study. Reports have
come from some centers of excellence in vascular
surgery describing good results with the use of pros-
thetic grafts alone, and these authors have noted that
these bypass procedures provide a better alternative
than primary amputation.16 Additionally, it has been
noted that the harvesting of arm vein requires for a sig-
nificantly greater effort than using prosthetic grafts,
and that a correspondingly significant increase in
patency and limb salvage should be achieved to justify
such efforts.14 In an attempt to determine the optimal
alternative conduit for lower extremity revasculariza-
tion, we have compared the results of bypass proce-
dures performed using all-autogenous bypass grafts
composed of multiple segments of arm vein with the
results obtained using composite prosthetic-autoge-
nous grafts. In doing so, we hoped to guide our future
selection of alternative conduit in the difficult clinical
situation in which the GSV is not available.
In the experience reported in this study with the
use of these two conduit types over the last 7 years,
it appears that arm vein, even when spliced together
with venovenostomy, results in superior clinical out-
comes. In this study, multisegment arm vein grafts
demonstrated significantly better primary and sec-
ondary patency, as well as limb salvage, in both
short- and long-term follow-up studies. Arm vein
proved superior regardless of bypass configuration,
and its effectiveness was not significantly diminished
in revision bypass procedures. In addition, the use of
arm vein did not lead to any increase in morbidity or
mortality in a patient population with considerable
comorbidities. Arm vein may also have the addition-
al potential advantage of a decreased susceptibility to
infection as compared with composite grafts con-
taining prosthetic material, although this was not
shown to be significant in this study.36
Several published reports have advocated the use
of composite prosthetic-autogenous grafts for lower
extremity revascularization.11,21-24 The procedures
were most frequently performed, as they were in this
trial, for limb salvage. The bypasses generally
required use of the tibial vessels for the distal anas-
tomosis, again consistent with this report. Three-
year cumulative patency rates between 20% and 35%
are most frequently reported.22-24 In occasional
instances, the 3-year primary patency has been
reported to be as high as 53%.23 These rates are
comparable with those described in this report for
composite sequential grafts—3-year primary, 43.7%;
limb salvage, 49.6%. These rates are significantly
lower than those achieved with multisegment arm
vein conduit. It is also worth noting that occasional-
ly these authors observed a persistently patent
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Fig 3. Life-table analysis of the variation in limb salvage
categorized by type of conduit. Limb salvage rates demon-
strate the greatest difference, with multisegment arm vein
grafts (solid line/solid circles) again being higher than com-
posite grafts (dashed line/open circles).
venous segment after thrombosis of the prosthetic
component of composite sequential grafts.21 This
was noted in two of the sequential composite grafts
in this study. These findings provide further support
for the preferential use of autogenous conduit in
lower extremity revascularization.
The use of an all-autogenous conduit appears to
be the most important factor in achieving the high-
est patency and limb salvage rates when it is neces-
sary to use conduit other than the GSV. Alternatives
to arm vein that have been proposed include the
lesser saphenous vein (LSV) and remnants of the
GSV.12,18,19 With the use of these alternative auto-
genous vein conduits, high long-term patency and
limb salvage rates have been achieved. And,
although harvest of the LSV may require placement
of the patient in the prone position with subsequent
repositioning to the supine position for performance
of the bypass procedure, use of the LSV for lower
extremity revascularization without repositioning
has been reported. Thus, use of the LSV and GSV
remnant provides a favorable alternative when the
ipsilateral GSV is not of sufficient length or quality.
It was not unexpected that greater than half of
the revascularization procedures in this study were
performed as revision, or “redo,” procedures since
in the majority of patients the absence of a suitable
ipsilateral GSV was attributable to its use for a previ-
ous bypass performed on that limb. This may high-
light the value of preserving the contralateral GSV
when possible. Interestingly, although primary pro-
cedures showed a slight trend toward improved
patency, the difference was small and not statistical-
ly significant. This finding may reflect a relatively
unfavorable arterial anatomy present in patients
requiring arm vein bypass as a primary revasculariza-
tion procedure.
In previous studies from this institution, primary
and secondary patency and limb salvage rates of
multiple segment arm vein grafts were indistinguish-
able from those of single-segment grafts. This is like-
ly the result of the fact that the site of venovenosto-
my was not significantly prone to stenosis and graft
failure in this study. Rather, bypass graft failure most
frequently resulted from progression of atheroscle-
rotic disease in the native arteries. Additionally, the
progression of intrinsic lesions within the vein graft
may lead to bypass graft failure. Chang et al37 have
reported their extensive experience with spliced vein
bypasses for infrainguinal arterial reconstruction.
They also obtained excellent long-term patency (4
years, 61%) and limb salvage (4 years, 85%-90%)
rates. Therefore, the need for multiple vein segments
and venovenostomies should not discourage the use
of these shorter vein segments.
In conclusion, several alternative conduit options
are available for use when an adequate ipsilateral
GSV is absent. The use of all-autogenous grafts
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Fig 4. Life-table analysis of limb salvage in femorotibial grafts categorized by conduit type.
Multisegment arm vein conduit (solid line/solid circles) demonstrated greater limb salvage rates than
did composite conduit (dashed line/open circles) in all graft configurations. Primary and secondary
patency rates were also greater for arm vein grafts.
when an alternative conduit is required appears to
provide the best results with regard to long-term
patency and limb salvage. With the use of alternative
autogenous vein conduits, however, it may often be
necessary to anastomose together 2 or more vein
segments. Though stenosis at the venovenostomy
site is a concern, this study demonstrates that the use
of multisegment arm vein grafts results in outcomes
that are clearly superior to those obtained by using
composite grafts composed of a combination of
prosthetic and autogenous material. The use of arm
vein as the first alternative for lower extremity revas-
cularization when the GSV is not available, as
reported here, has resulted in long-term patency and
limb salvage rates that meet or exceed those report-
ed for other alternative conduits, while preserving
the contralateral GSV for subsequent use. In addi-
tion, these patency and limb salvage rates were
achieved without a significant increase in morbidity
or mortality in a patient population with extensive
comorbid conditions.
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DISCUSSION
Dr LaMuraglia (Boston, Mass). I enjoyed your paper.
Thank you very much. I think that we all agree that all
autogenous conduit, especially for these distal reconstruc-
tions, is very important. The one thing I would like to ask
is when you discuss your issue of a composite, are you pri-
marily discussing a composite using a prosthetic graft
going to a vein without a composite sequential configura-
tion, or have efforts been done to try to perform the com-
posite sequential by going to maybe an isolated popliteal
segment with the composite and then using a segment of
cephalic or other vein to go to the tibial to improve the
runoff to the foot, which is necessary in a lot of these
patients for limb salvage. The data in the past have shown
that composite sequentials are actually far superior in
terms of long-term patency than regular composite.
Dr Faries (Boston, Mass). In this study of the 31 com-
posite grafts, 12 were performed in the sequential configu-
ration in which a prosthetic graft was taken to an isolated
arterial segment, and an autogenous vein was then used
either from a combined anastomosis or from further distal-
ly on that segment for the tibial or pedal revascularization.
In 10 cases a common ostium anastomosis was used, and
in seven causes a direct anastomosis between the compos-
ite conduit and the arm vein was performed. Interestingly,
in two of the patients who had the sequential configura-
tion, failure of the prosthetic component occurred while
the venous component remained patent in those patients.
Dr Conte (Boston, Mass). Peter, I congratulate you on
your presentation and also on the outstanding results that
your group has shown with arm vein conduits. I rise just
to ask about the contralateral saphenous vein issue that I
think continues to puzzle me a little bit. I think numerous
reports have now established that the incidence of requir-
ing it subsequently for coronary bypass is fairly low, prob-
ably because the diseases occur at a different time in the
average patient’s life span. What percentage of your
patients had contralateral saphenous vein available, and
then how many went on to actually need it for something
else? In what situations do you entertain using contralat-
eral saphenous vein?
Dr Faries. Rarely do we entertain using the contralater-
al saphenous vein, and I think that is because our patient
population exhibits a number of the factors that would
make its use for contralateral lower extremity revascular-
ization more likely in follow-up. These factors have been
elucidated nicely by the Dartmouth group and include the
existence of a low ABI in the contralateral side, the pres-
ence of diabetes, and the presence of coronary artery dis-
ease. In addition, in our patients 46% of those patients at
the time of presentation do not possess a contralateral
greater saphenous vein that is usable, and in follow-up of
those patients who did possess it, 23% ultimately needed
revascularization of the contralateral side. This was with a
mean follow-up of 14.9 months, so a significant propor-
tion of those patients in our patient population will ulti-
mately require revascularization of the contralateral side. I
think that would vary from population to population, and
specific vascular centers should determine the likelihood of
contralateral lower extremity revascularization in their
patients individually.
Dr Conte. Was that predictable, though? I mean, if you
had a patient who had a relatively good ABI in the other
leg, would you ever consider using that vein?
Dr Faries. The contralateral saphenous vein has been
used at our center, and the decision to use it is made by
the operating sugeon.
Dr Darling (Albany, NY). Dr Faries, again that was
another superb paper presented by you from the
Deaconess group. Like most of us here we have all been
privileged with performing many spliced vein reconstruc-
tions. In the last 450 splice vein reconstructions that we
have performed, we have had to alter our surveillance of
these bypasses because of the fact that about 20% of them
will have a stenosis revised possibly because of using dis-
advantaged conduits for these spliced vein reconstruc-
tions. Have you altered your surveillance protocol for
these as opposed to the single segment veins?
Dr Faries. Our follow-up protocol is slightly different.
We are more aggressive in terms of imaging these patients
with duplex ultrasonography. We do not necessarily use
duplex ultrasonography in all patients with revasculariza-
tion procedures, but our threshold for performing that in
follow-up is lower in these spliced arm vein segment
patients.
Unidentified Speaker. Peter, that was a very nice paper
and thanks for bringing us a contemporary series of com-
posite grafts. In the old days people would say that when
you had composite grafts vein plus plastic that the overall
patency would revert to that of the prosthetic graft. Is that
pretty much what you think is going on here?
Dr Faries. These composite grafts demonstrate a slight-
ly greater patency in limb salvage rates than primary pros-
thetic grafts to tibial vessels, at least in the majority of
series and in the randomized trials, multicenter trials. So it
may be slightly better than prosthetic alone, although
some authors, particularly Dr Pappas and Dr Hobson in
New Jersey, have reported superior patency rates with tib-
ial vessel bypass grafts performed using a vein cuff.
Unidentified Speaker. Another question if I may. It has
also been touted that once you manipulate a vein in any
way—you patch it, you splice it—that that has a really sig-
nificant negative impact on patency. How do your data
compare with a contemporary series of unmanipulated
vein grafts?
Dr Faries. We have compared with our patients this
series of patients who required only a single segment of
arm vein to perform their bypass. In the overall patency
rates there was no significant difference, and no difference
was present in the limb salvage rates. It may be the threat
of intimal hyperplasia at the venovenostomy is not as 
significant as we had thought it would be, since in over 520
procedures we did not determine a significant difference
between single segment and multisegment arm vein grafts.
Dr Cronenwett (Lebanon, NH). Peter, I enjoyed this
also. Although my biases support your conclusion that
these composite vein grafts are better, another interpreta-
tion of your data would be that since these composite
prosthetic vein grafts had to be used more often in the
redo scenario, you showed a nice graph that showed in the
redo situation there was no difference. So then would not
an alternate explanation be that the redo nature of the
procedure explains the result, rather than the nature of the
conduit.
Dr Faries. There was no significant difference in terms
of primary versus redo procedures between multisegment
arm vein grafts and composite prosthetic-autogenous
grafts. We have not analyzed the data on the basis of that
factor alone, but it does not appear to account for the
marked differences observed between these two types of
arterial conduits.
Dr Jackson (Northampton, Mass). I wondered in your
venovenostomy the technique that you use. Do you suture
or do you use the extrusion vascular clip technique?
Dr Faries. 7-0 Prolene sutures are used for the ven-
ovenostomy.
Dr Cambria (Boston, Mass). Peter, nice paper. One
comment and one question. I think it is fair to say that
your data, with respect to the equivalent performance of
multiple splice vein grafts as opposed to a single conduit,
are certainly different than reported by some others. My
question relates to your adjunctive treatment of patients
with disadvantaged prosthetic autogenous composite con-
duits. What is your policy about anticoagulation in these
patients, and do you think that might make a difference?
Dr Faries. Anticoagulation is most typically used for
prosthetic grafts that extend below the knee in any con-
figuration. These patients receive long-term anticoagula-
tion with Coumadin.
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